Does TACROLIMUS Cause Disease progression? 779 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 779 reports of Disease progression have been filed in association with TACROLIMUS (Tacrolimus). This represents 0.9% of all adverse event reports for TACROLIMUS.
779
Reports of Disease progression with TACROLIMUS
0.9%
of all TACROLIMUS reports
195
Deaths
226
Hospitalizations
How Dangerous Is Disease progression From TACROLIMUS?
Of the 779 reports, 195 (25.0%) resulted in death, 226 (29.0%) required hospitalization, and 48 (6.2%) were considered life-threatening.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TACROLIMUS. However, 779 reports have been filed with the FAERS database.
What Other Side Effects Does TACROLIMUS Cause?
Off label use (8,718)
Drug ineffective (6,214)
Product use in unapproved indication (5,057)
Acute kidney injury (4,005)
Transplant rejection (3,526)
Cytomegalovirus infection (3,320)
Covid-19 (3,201)
Drug interaction (2,896)
Diarrhoea (2,854)
Toxicity to various agents (2,845)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which TACROLIMUS Alternatives Have Lower Disease progression Risk?
TACROLIMUS vs TACROLIMUS\TACROLIMUS ANHYDROUS
TACROLIMUS vs TADALAFIL
TACROLIMUS vs TAFAMIDIS
TACROLIMUS vs TAFAMIDIS MEGLUMINE
TACROLIMUS vs TAFASITAMAB